NRAS and melanoma: Even though loss-of-heterozygosity is uncommon in NRAS-driven human malignancies (Supplementary Fig. 4a–c), NRAS61R was unable to drive melanoma formation in the presence of wild-type NRAS61Q (Fig. 2e).